Archive for January, 2009

 

During Fertility Treatment Anxiety And Depression Do Not Affect Pregnancy And Treatment Cancellation Rates

January 31st, 2009

Anxiety and depression before and during fertility treatment does not affect the likelihood of a woman becoming pregnant or of her cancelling her treatment, according to a study published in Europe’s leading reproductive medicine journal, Human Reproduction [1] on Thursday 29 January.
Dr Bea Lintsen, a physician at the Department of Obstetrics and Gynaecology, Radboud University […]

Read full article | Comments Off

Understanding The Sleep-Wake Cycle

January 30th, 2009

Lack of sleep is a common complaint but for many, falling asleep involuntarily during the day poses a very real and dangerous problem. A new study from the Montreal Neurological Institute (MNI) at McGill University demonstrates interestingly, that sleep-wake states are regulated by two different types of nerve cells (neurons), melanin-concentrating hormone (MCH) neurons and […]

Read full article | Comments Off

Water Released Into The St. Lawrence River Contains Hypertension And Cholesterol Medications

January 29th, 2009

A study conducted by Universit?© de Montr?©al researchers on downstream and upstream water from the Montreal wastewater treatment plant has revealed the presence of chemotherapy products and certain hypertension and cholesterol medications.
Bezafibrate (cholesterol reducing medication), enalapril (hypertension medication), methotrexate and cyclophosphamide

Read full article | Comments Off

Cutting Salt Isn’t The Only Way To Reduce Blood Pressure

January 28th, 2009

Most people know that too much sodium from foods can increase blood pressure.
A new study suggests that people trying to lower their blood pressure should also boost their intake of potassium, which has the opposite effect to sodium.
Researchers found that the ratio of sodium-to-potassium in subjects’ urine was a much stronger

Read full article | Comments Off

Rasilez HCT®, Single-pill Combination Of Rasilez® And Diuretic, Receives Swiss Approval For The Treatment Of High Blood Pressure

January 27th, 2009

Rasilez HCT® (aliskiren and hydrochlorothiazide), a single-pill combination of two high blood pressure medicines - first-in-class direct renin inhibitor Rasilez® (aliskiren) and the diuretic hydrochlorothiazide (HCT) - has been approved by Swissmedic as a new treatment for high blood pressure.
High blood

Read full article | Comments Off

Leading Dietitian Scoops National Recognition, Epsom General Hospital, England

January 26th, 2009

A leading dietitian based at Epsom General Hospital has been crowned ‘Dietitian of the Year’ by a national charity. Kristina Zaremba who has been working in the field for the past 28 years, said she was delighted with the accolade, awarded to her by Coeliac UK.
The charity supports people with coeliac disease - a condition […]

Read full article | Comments Off

Risk Of Post-Traumatic Stress Disorder May Be Reduced By Large Hormone Dose

January 25th, 2009

A new study by Ben-Gurion University of the Negev (BGU) researchers found that a high dose of cortisone could help reduce the risk of post-traumatic stress disorder (PTSD). The article appears in Biological Psychiatry, Volume 64, Issue 8, pages 708-717.
In an animal model of PTSD, high doses of a cortisol-related substance, corticosterone, prevented negative consequences

Read full article | Comments Off

Medication May Provide Some Benefit For Older Adults With Anxiety Disorder

January 24th, 2009

Preliminary research suggests that use of the drug escitalopram provided some improvement in symptoms for older adults with generalized anxiety disorder, although the overall benefits were diminished because of nonadherence to the drug by some patients, according to a study in the January 21 issue of JAMA.
Generalized anxiety disorder (GAD), one of the most common […]

Read full article | Comments Off

Four Innovative Novartis Medicines For Cancer, Asthma, High Blood Pressure And Wet AMD Approved In Japan

January 22nd, 2009

Patients in Japan stand to benefit from the approval of four innovative medicines - Tasigna® for the treatment of a life-threatening form of leukemia, Xolair® for severe asthma, Co-Dio® for high blood pressure, and Lucentis® for wet age-related macular degeneration (AMD), an eye disease that is a major cause of blindness in people over the […]

Read full article | Comments Off

Remuda Ranch Reports More Women Seek To Be Thin During Pregnancy

January 21st, 2009

Remuda Ranch Programs for Eating and Anxiety Disorders (), the nation’s leading eating disorder treatment center, reports there’s a new pressure to look perfect while pregnant.
"With the media giving so much focus to pregnant celebrities, there’s an increased pressure to look perfect and thin during pregnancy," said Brenda Woods, MD, director of medical services at […]

Read full article | Comments Off

Osteoporosis? Look Out For Depression

January 20th, 2009

A review article which is published in the current issue of the European Journal Psychotherapy and Psychosomatics analyzes the relationship between depression and bone metabolism.
This study reveals that the association between psychiatric illness, in particular depression, and osteoporosis has been the subject of a growing

Read full article | Comments Off

Oxford Authority Leads Student Suicide Seminar

January 19th, 2009

Professor Mark Williams from the Centre for Suicide Research, University of Oxford, is the keynote speaker at a one-day student suicide prevention seminar being organised by PAPYRUS, the national charity dedicated to prevention of young suicide. It takes place on Thursday 19 February at The Oxford Centre, 333 Banbury Road, Oxford OX2 7PL.
Every year in […]

Read full article | Comments Off

Pharmacy Chain Allows Men To Get Erectile Dysfunction Drugs Without Visiting Their GP, UK

January 18th, 2009

generic propecia online buy A new service which allows men to get erectile dysfunction drugs legitimately without having to visit their GP for a prescription has been launched.
The new service - a UK first - is being launched by Lloydspharmacy in partnership with sexual health experts Dr Thom, The service offers online diagnosis

Read full article | Comments Off

Postnatal Depression Can Be Effectively Treated And Possibly Prevented

January 17th, 2009

Health visitors can be trained to identify women with postnatal depression and offer effective treatment, while telephone peer support (mother to mother) may halve the risk of developing postnatal depression, suggests research published on today.
About 13% of women experience postnatal depression in the year following the birth of their child. But postnatal depression

Read full article | Comments Off

Walking On A Treadmill Helped PAD Patients

January 16th, 2009

A new study from the US found that patients with peripheral arterial disease (PAD), which is sometimes accompanied by pain in leg muscles,
improved their walking endurance and quality of life by taking part in a treadmill walking exercise that also helped patients who did not have the
classic symptoms of pain in the legs.
The study was […]

Read full article | Comments Off

High Caffeine Intake Linked To Hallucination Proneness

January 15th, 2009

High caffeine consumption could be linked to a greater tendency to hallucinate, a new research study suggests.
People with a higher caffeine intake, from sources such as coffee, tea and caffeinated energy drinks, are more likely to report hallucinatory experiences such as hearing voices and seeing things that are not there, according to the Durham University […]

Read full article | Comments Off

Rexahn Pharmaceuticals Receives FDA Approval To Initiate Phase II Trial For Serdaxin In Patients With Major Depressive Disorders

January 14th, 2009

Rexahn Pharmaceuticals, Inc. (AMEX: RNN), a leader in innovative therapeutics for life-threatening and life-debilitating diseases, announced that the Company has received FDA approval to begin Phase II trials for Serdaxin™, for the treatment of major depressive disorders (MDD).
This trial represents the third Phase II study currently in progress at Rexahn Pharmaceuticals. The Company’s

Read full article | Comments Off

American Lung Association Study Finds No Evidence Of Depression Or Suicide Linked To Asthma And Allergy Drug Montelukast

January 13th, 2009

There has been recent
concern that suicide may be a complication of montelukast (Singulair)
therapy. Montelukast is a Food and Drug Administration (FDA) approved oral
drug that has been prescribed for more than a decade for the treatment of […]

Read full article | Comments Off

Preventing Teenage Depression By Recognizing Children’s Successes In All Areas

January 12th, 2009

Students’ successes in the first grade can affect more than their future report cards. In a new study, University of Missouri researchers found links among students’ weak academic performance in the first grade, self-perceptions in the sixth grade, and depression symptoms in the seventh grade.
"We found that students in the first grade who struggled academically […]

Read full article | Comments Off

Cleviprex™ Receives FDA Approval - First New IV Antihypertensive Treatment Approved In Ten Years

January 11th, 2009

The Medicines Company (NASDAQ: MDCO) announced that the U.S. Food and Drug Administration (FDA) has approved the intravenous (IV) therapy CleviprexTM (clevidipine butyrate) injectable emulsion for the reduction of blood pressure when oral therapy is not feasible or not desirable.
Cleviprex, a novel IV antihypertensive, represents an advancement over currently available therapies, providing rapid and […]

Read full article | Comments Off

Teens Should Be Taught How To Handle School Stress

January 10th, 2009

Teenagers are turning to alcohol and cigarettes to relieve school stress. generic acomplia online buy This is the finding of a study presented at The British Psychological Society’s Division of Educational and Child Psychology annual conference.
The study carried out by psychologist Dr Pamela Taylor at Salford Local Authority looked at the stressors

Read full article | Comments Off

Studies Look At High Blood Pressure Control Among Blacks, Weight-Loss Methods

January 9th, 2009

The following summarizes studies published in the January issue of the Journal of the National Medical Association.
"A Proposed New Model of Hypertensive Treatment Behavior in African-Americans" (.pdf): In the report, Jennifer Middleton, assistant medical director of the University of Pittsburgh Medical Center’s St. Margaret Bloomfield-Garfield

Read full article | Comments Off

News From The Journal Of Neuroscience, 6-Jan-2009

January 8th, 2009

Joris de Wit, Ruud F. Toonen, and Matthijs Verhage.
Neurons secrete neuropeptides, neurotrophic factors, guidance molecules, and proteases via secretory dense-core vesicles. Although secretion of such molecules has been extensively studied in neuroendocrine cells, relatively little is known about release of these molecules by neurons. To remedy this, de Wit et al. labeled neuropeptide Y, brain-derived […]

Read full article | Comments Off

Childhood Trauma And Risk For Chronic Fatigue Syndrome Connected By Biological Link

January 7th, 2009

Childhood trauma is a potent risk factor for development of chronic fatigue syndrome (CFS), according to a study by researchers at Emory University School of Medicine and the Centers for Disease Control and Prevention (CDC). The study is published in the Jan. 5, 2009Archives of General Psychiatry.
Results of the study confirm

Read full article | Comments Off

Use Of Low-Cost Diuretics To Treat High Blood Pressure Did Not Increase After Study Showing Effectiveness

January 6th, 2009

The use of low-cost, generic diuretics to treat high blood pressure did not increase significantly following a 2002 study that found the drugs were more effective at treating hypertension than newer drugs that were up to 20 times more expensive, the New York Times reports. The

Read full article | Comments Off